Verwandte Artikel zu Circulating biomarkers for diagnosis, prognosis and...

Circulating biomarkers for diagnosis, prognosis and treatment response prediction in cancer - Part A: Volume 391 (International Review of Cell and Molecular Biology, Volume 391) - Hardcover

 
9780443345296: Circulating biomarkers for diagnosis, prognosis and treatment response prediction in cancer - Part A: Volume 391 (International Review of Cell and Molecular Biology, Volume 391)
Hardcover
ISBN 10: 0443345295 ISBN 13: 9780443345296
Verlag: Academic Press, 2025

Inhaltsangabe

Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer Patients, Part A, Volume 391 delves into the crucial role of circulating biomarkers in cancer diagnosis and treatment monitoring. Specific chapters in this new release include Circulating biomarkers for diagnosis and response to therapies in cancer patients, Identification of circulating tumor DNA as a biomarker for diagnosis and response to therapies in cancer patients, Identification of cell-free circulating epigenomic biomarkers for early diagnosis and response to therapies in breast cancer patients, Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer, and much more.

This comprehensive work explores the various types of biomarkers, their significance in early cancer detection, prognostication, and evaluation of therapeutic responses. It covers cutting-edge research on circulating tumor cells, cell-free DNA, exosomes, and other biomarkers that can revolutionize cancer management. Additionally, it discusses the challenges, advancements, and future prospects of utilizing circulating biomarkers in personalized cancer care.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Über die Autorinnen und Autoren

Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology.

Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals:
OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.

Sheila Spada is at Weill Cornell Medical College, NY, USA

Von der hinteren Coverseite

Identification of Circulating Biomarkers for Diagnosis and Response to Therapies in Cancer Patients Part A delves into the crucial role of circulating biomarkers in cancer diagnosis and treatment monitoring. This comprehensive work explores the various types of biomarkers, their significance in early cancer detection, prognostication, and evaluation of therapeutic responses. The book covers cutting-edge research on circulating tumor cells, cell-free DNA, exosomes, and other biomarkers that can revolutionize cancer management. Additionally, it discusses the challenges, advancements, and future prospects of utilizing circulating biomarkers in personalized cancer care, ultimately aiming to enhance patient outcomes and precision medicine strategies.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Verlag
Academic Press
Erscheinungsdatum
2025
Sprache
Englisch
ISBN 10 
0443345295
ISBN 13 
9780443345296
Einband
Gebundene Ausgabe
Auflage
1
Anzahl der Seiten
274
Herausgeber
Galluzzi
Kontakt zum Hersteller
Elsevier Science & Technology
tradeorders@elsevier.com

London Wall 125
London
EC2Y 5AS
Vereinigtes Königreich
Verantwortliche Person
gpsr@libri.de
gpsr@libri.de

Europaallee 1
Bad Hersfeld
36244
Deutschland